Daniel Barocas, MD, MPH, associate professor of Urology, is being recognized with a national award from the Society of Urologic Oncology (SUO) for his efforts to develop urologic cancer quality measures.

Vanderbilt urologic surgeons are offering an alternative therapy for prostate cancer patients considered to be low-to-intermediate risk, a middle ground between active surveillance and aggressive therapy.

An interdisciplinary collaboration of engineers and doctors at Vanderbilt and Columbia Universities has designed a robotic microsurgery system specifically designed to treat bladder cancer, the sixth most common form of cancer in the U.S. and the most expensive to treat.